Palo Alto Networks, Inc. R&D decreased by 3.2% to $511.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $505.00M to $511.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 14.8% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $311.00M | $325.30M | $339.50M | $359.00M | $355.40M | $363.80M | $371.80M | $404.10M | $413.70M | $414.40M | $409.50M | $447.90M | $457.20M | $494.80M | $481.00M | $505.00M | $494.50M | $503.50M | $528.00M | $511.00M |
| QoQ Change | — | +4.6% | +4.4% | +5.7% | -1.0% | +2.4% | +2.2% | +8.7% | +2.4% | +0.2% | -1.2% | +9.4% | +2.1% | +8.2% | -2.8% | +5.0% | -2.1% | +1.8% | +4.9% | -3.2% |
| YoY Change | — | — | — | — | +14.3% | +11.8% | +9.5% | +12.6% | +16.4% | +13.9% | +10.1% | +10.8% | +10.5% | +19.4% | +17.5% | +12.7% | +8.2% | +1.8% | +9.8% | +1.2% |